Is Boston Scientific Stock a Good Investment?
Boston Scientific Investment Advice | BSX |
- Examine Boston Scientific's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Boston Scientific's leadership team and their track record. Good management can help Boston Scientific navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Medical Equipment space and any emerging trends that could impact Boston Scientific's business and its evolving consumer preferences.
- Compare Boston Scientific's performance and market position to its competitors. Analyze how Boston Scientific is positioned in terms of product offerings, innovation, and market share.
- Check if Boston Scientific pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Boston Scientific's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Boston Scientific Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Boston Scientific Corp is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Boston Scientific Stock
Researching Boston Scientific's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 94.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.85. Boston Scientific Corp had not issued any dividends in recent years. The entity had 2:1 split on the 6th of November 2003.
To determine if Boston Scientific is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Boston Scientific's research are outlined below:
| Over 94.0% of the company shares are held by institutions such as insurance companies |
Boston Scientific uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Boston Scientific Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Boston Scientific's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Boston Scientific's market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 158.24 B.Boston Scientific's profitablity analysis
The company has Net Profit Margin of 0.14 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.19 %, which entails that for every 100 dollars of revenue, it generated $0.19 of operating income.Determining Boston Scientific's profitability involves analyzing its financial statements and using various financial metrics to determine if Boston Scientific is a good buy. For example, gross profit margin measures Boston Scientific's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Boston Scientific's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Boston Scientific's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Boston Scientific Corp. Check Boston Scientific's Beneish M Score to see the likelihood of Boston Scientific's management manipulating its earnings.
Basic technical analysis of Boston Stock
As of the 5th of August, Boston Scientific shows the Downside Deviation of 1.09, mean deviation of 0.8483, and Risk Adjusted Performance of 0.0287. Boston Scientific Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Boston Scientific's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Boston Scientific insiders, such as employees or executives, is commonly permitted as long as it does not rely on Boston Scientific's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Boston Scientific insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Joseph Fitzgerald over three months ago Acquisition by Joseph Fitzgerald of 60 shares of Boston Scientific subject to Rule 16b-3 | ||
Joseph Fitzgerald over six months ago Disposition of 11236 shares by Joseph Fitzgerald of Boston Scientific subject to Rule 16b-3 | ||
Arthur Butcher over six months ago Disposition of 14010 shares by Arthur Butcher of Boston Scientific at 89.2694 subject to Rule 16b-3 | ||
Wendy Carruthers over six months ago Disposition of 1197 shares by Wendy Carruthers of Boston Scientific at 24.55 subject to Rule 16b-3 | ||
Wendy Carruthers over a year ago Disposition of 6983 shares by Wendy Carruthers of Boston Scientific at 66.89 subject to Rule 16b-3 | ||
Daniel Brennan over a year ago Disposition of 1644 shares by Daniel Brennan of Boston Scientific at 65.82 subject to Rule 16b-3 | ||
Tobin James R over a year ago Exercise or conversion by Tobin James R of 100000 shares of Boston Scientific subject to Rule 16b-3 |
Boston Scientific's Outstanding Corporate Bonds
Boston Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Boston Scientific Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Boston bonds can be classified according to their maturity, which is the date when Boston Scientific Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BOSTON PPTYS LTD Corp BondUS10112RAY09 | View | |
| BOSTON PPTYS LTD Corp BondUS10112RAX26 | View | |
| BXP 675 01 DEC 27 Corp BondUS10112RBG83 | View | |
| BOSTON SCIENTIFIC P Corp BondUS101137AL15 | View | |
| BXP 245 01 OCT 33 Corp BondUS10112RBF01 | View | |
| BOSTON PROPERTIES LP Corp BondUS10112RBE36 | View | |
| BOSTON PROPERTIES LP Corp BondUS10112RBD52 | View |
Understand Boston Scientific's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Boston Scientific's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0287 | |||
| Market Risk Adjusted Performance | 0.063 | |||
| Mean Deviation | 0.8483 | |||
| Semi Deviation | 0.9837 | |||
| Downside Deviation | 1.09 | |||
| Coefficient Of Variation | 3130.49 | |||
| Standard Deviation | 1.15 | |||
| Variance | 1.33 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | (0.08) | |||
| Treynor Ratio | 0.053 | |||
| Maximum Drawdown | 6.18 | |||
| Value At Risk | (1.72) | |||
| Potential Upside | 1.75 | |||
| Downside Variance | 1.19 | |||
| Semi Variance | 0.9677 | |||
| Expected Short fall | (0.94) | |||
| Skewness | 0.7416 | |||
| Kurtosis | 2.4 |
| Risk Adjusted Performance | 0.0287 | |||
| Market Risk Adjusted Performance | 0.063 | |||
| Mean Deviation | 0.8483 | |||
| Semi Deviation | 0.9837 | |||
| Downside Deviation | 1.09 | |||
| Coefficient Of Variation | 3130.49 | |||
| Standard Deviation | 1.15 | |||
| Variance | 1.33 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | (0.08) | |||
| Treynor Ratio | 0.053 | |||
| Maximum Drawdown | 6.18 | |||
| Value At Risk | (1.72) | |||
| Potential Upside | 1.75 | |||
| Downside Variance | 1.19 | |||
| Semi Variance | 0.9677 | |||
| Expected Short fall | (0.94) | |||
| Skewness | 0.7416 | |||
| Kurtosis | 2.4 |
Consider Boston Scientific's intraday indicators
Boston Scientific intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Boston Scientific stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Boston Scientific time-series forecasting models is one of many Boston Scientific's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Boston Scientific's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Boston Stock media impact
There is far too much social signal, news, headlines, and media speculation about Boston Scientific that are available to investors today. This information is accessible both publicly - through Boston Scientific's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Boston-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Boston Scientific news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Boston Scientific relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Boston Scientific's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Boston Scientific alpha.
Boston Scientific Corporate Directors
| Edward Ludwig | Lead Independent Director | Profile | |
| Donna James | Independent Director | Profile | |
| Stephen MacMillan | Independent Director | Profile | |
| Ellen Zane | Independent Director | Profile |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.